Skip To Main Content
Rajee Antony on Muck Rack

Rajee Antony

As seen in: ONCOLOGY journal
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Rajee

Contact Rajee, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

17 A Clinical Systematic Literature Review of Treatments Among Patients With Advanced/ Metastatic HER2+ Breast Cancer

|
By Kerigo Ndirangu, Vanita Tongbram, Bagrat Lalayan, Joyce O’Shaughnessy, Rachel Goldgrub, Rajee Antony, Sarah E. Schellhorn
| ONCOLOGY journal Verified
Background The incidence of breast cancer (BC) has continued to rise rapidly and is a leading cause of cancer death. Human epidermal growth factor receptor 2–positive (HER2+) BC is approximately 20% of all invasive BC. Recent advances in chemotherapy and targeted treatments against HER2 have significantly improved the prognosis of HER2+ BC. Pertuzumab (Pmab) + trastuzumab (Tmab) + docetaxel (DOC) has been approved for the first-line (1L) treatment of patients with HER2+ metastatic BC.
Open in Who Shared Issue with article?
See all 1 articles